The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

The main types of weight loss injections are GLP-1 agonists (Ozempic and Wegovy), dual agonists (Zepbound and Mounjaro) and lipotropic injections (Kybella is the only one that is FDA-approved ...

The current list price in the U.S. for a one-month supply (defined as four weekly injections used over 28 days) of Wegovy (semaglutide) and Saxenda (liraglutide) is $1,349, and Zepbound ...

Weight loss injections are prescription medications ... Some people who may not be able to receive Ozempic include: Zepbound works by activating the GLP-1 and glucose-dependent insulinotropic ...

Mounjaro and Zepbound are part of a wave of diabetes and obesity medications known as GLP-1 receptor agonists that are soaring in popularity globally due to the amount of weight people lose while ...